Clinical Research Directory
Browse clinical research sites, groups, and studies.
Study to Evaluate the Impact of the Use of Alternative and Complementary Therapies on Therapeutic Adherence in Patients Treated With taMoxifen for Early Stage Breast Cancer
Sponsor: Institut Claudius Regaud
Summary
This is a pilot, prospective, interventional, monocentric study designed to evaluate, in a real-life situation, adherence to tamoxifen treatment as a function of the taking of alternative and complementary therapies in patients with localized hormone-dependent breast cancer. 200 patients will be included in the study. Each patient will be followed for one day.
Official title: Pilot Study to Evaluate the Impact of the Use of Alternative and Complementary Therapies on Therapeutic Adherence in Patients Treated With taMoxifen for Early Stage Breast Cancer
Key Details
Gender
FEMALE
Age Range
18 Months - Any
Study Type
INTERVENTIONAL
Enrollment
200
Start Date
2021-02-12
Completion Date
2026-02
Last Updated
2025-04-10
Healthy Volunteers
No
Conditions
Interventions
Treatment requiring adjuvant Hormonal Therapy (HT) with tamoxifen.
Each included patient will be referred to the health care staff for a blood sample: * for the determination of the residual plasma concentration of tamoxifen and its active metabolites, * for the constitution of a biobank. Patients will then complete a questionnaire to collect information on tamoxifen intake and adherence (via the GIRERD questionnaire), as well as possible Alternative and Complementary Therapeutics (ACT) intake (reason for use, type of ACT, ...).
Locations (1)
Institut Universitaire du Cancer de Toulouse - Oncopole
Toulouse, France